Jelena Grahovac

5PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma.

|Jan 10, 2026
Newly Synthesized Telmisartan-Amino Acid Conjugates Exhibit Enhanced Cytotoxic Effects in Malignant Melanoma Cells.

Dragana Vukadinović, Ana Damjanović, Miodrag Vuković

|Dec 17, 2024
Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy.

Jelena Grahovac, Ana Đurić, Miljana Tanić

|May 23, 2024
Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology.

Marija Ostojić, Ana Đurić, Kristina Živić

|Jun 29, 2023
Nischarin expression may have differing roles in male and female melanoma patients.

Marija Ostojić, Marko Jevrić, Olivera Mitrović-Ajtić

Pageof 1

Frequent Collaborators

2 joint publications

Marija Ostojić

2 joint publications

Kristina Živić

2 joint publications

Miljana Tanić

2 joint publications

Tatjana Srdić-Rajić